Genetic and Chemical Capsid Modifications of Adenovirus Vectors to Modulate Vector–Host Interactions
Adenovirus-based vectors are playing an important role as efficacious genetic vaccines to fight the current COVID-19 pandemic. Furthermore, they have an enormous potential as oncolytic vectors for virotherapy and as vectors for classic gene therapy. However, numerous vector–host interactions on a ce...
Main Authors: | Denice Weklak, Daniel Pembaur, Georgia Koukou, Franziska Jönsson, Claudia Hagedorn, Florian Kreppel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/7/1300 |
Similar Items
-
Capsid and Genome Modification Strategies to Reduce the Immunogenicity of Adenoviral Vectors
by: Florian Kreppel, et al.
Published: (2021-02-01) -
Hexon modification of human adenovirus type 5 vectors enables efficient transduction of human multipotent mesenchymal stromal cells
by: Robin Nilson, et al.
Published: (2022-06-01) -
Development of capsid- and genome-modified optimized AAVrh74 vectors for muscle gene therapy
by: Jakob Shoti, et al.
Published: (2023-12-01) -
Progress in Adenoviral Capsid-Display Vaccines
by: Marija Vujadinovic, et al.
Published: (2018-07-01) -
Insights from the Construction of Adenovirus-Based Vaccine Candidates against SARS-CoV-2: Expecting the Unexpected
by: Denice Weklak, et al.
Published: (2023-10-01)